about
Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical reviewChanging epidemiological trends of inflammatory bowel disease in AsiaInflammatory bowel disease associated neoplasia: A surgeon's perspectiveSelf-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical careRNA interference-based nanosystems for inflammatory bowel disease therapyPolyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal CancerObesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.Protective effects of heat-killed Lactococcus lactis subsp. lactis BF3, isolated from the intestine of chum salmon, in a murine model of DSS-induced inflammatory bowel disease.Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.Hydrogen sulfide from a NaHS source attenuates dextran sulfate sodium (DSS)-induced inflammation via inhibiting nuclear factor-κBCytokine Networks and T-Cell Subsets in Inflammatory Bowel DiseasesFerulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, oxidative stress, iNOs, COX-2, and apoptosis in laboratory rats.Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification.The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis.Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease.Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010.Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.ROS in gastrointestinal inflammation: Rescue Or Sabotage?Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function.Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.Integrating Adolescents and Young Adults into Adult-Centered Care for IBD.Investigating cell therapy for inflammatory bowel disease.Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe.Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.The gut microbiota and inflammatory bowel diseases.Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut.The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study.Clonal evolution of colorectal cancer in IBD.Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
P2860
Q26748735-829DE841-374B-4BDB-973B-E851F731310FQ26749910-29115889-4B11-4502-8DB5-3F73AD169A90Q26774592-82F63BC4-1634-4756-A117-6E2D2AC52796Q28070335-6E26966F-F16D-43F2-9FB0-50C6D4167D7FQ28071518-45E16131-8CE9-4CD3-85E7-9887D12EECC7Q28071957-723461F1-D123-40C7-8EF3-9BB66B8DB625Q30239737-7E5BA231-8BC7-41D2-ADC5-C95E645330F6Q30244767-A85C431A-4153-4874-B637-45EDAA100E3BQ33711741-FB251518-6068-4CDF-AE7C-98B5E44AE6F3Q33749513-28D67712-3045-46C1-8567-98F56F714218Q33786052-2CB8C337-86DE-4373-80EA-96E3205D40B0Q33805916-07B865E1-743C-4120-BED4-A7B14E9A8D48Q36095561-95B92F56-7A93-454F-8188-5E20FD49EAA2Q36099943-AF2A0B32-9A7C-465A-94E7-9D224A6472ECQ36101681-44244670-9A7B-471F-9719-D51FC633E50AQ36693578-71910443-10B1-483C-BF0D-4F7C7B4E6396Q36818290-C2F6E949-5D8E-421F-9570-F0CB69995482Q37373719-4C663E0D-AEAF-424B-A56E-E420C2B1A966Q37540222-3FC19AA9-0881-4148-847F-9064C7978A97Q37686653-ABF5D3E1-6655-4911-88B7-EF64D02395A0Q37724463-8EC636CC-3AB9-4C17-B42F-9B5C6DCBB95CQ37729846-52E9814B-5685-47CF-A664-15AE6BBDE99EQ38372199-8CCF5802-C78C-4754-B10A-6519280C9EAEQ38662852-2B661D4F-748B-4D10-BB82-17A34FD054AEQ38693962-78AB2E2F-8EBD-4950-AF60-ED0EC40D4BF7Q38696638-0F6EDADB-D72B-4C46-A0E4-DED249329028Q38726458-ED4FDFFB-02F0-40CE-934E-371EFF18ED14Q38768891-81A07A88-B8B1-43E3-BAC8-FAA5AAFD6E36Q38775580-CA760A28-4DEF-4C80-AB79-59D679DF10E3Q38810109-FFA3EF3A-0E7C-4036-9A1F-A1DC67947C59Q38817393-89F6A244-FE13-4FC7-88EC-65F013B4FF73Q38824505-C83254F2-1BE0-4565-B3E0-FAD497EACAD9Q38832962-A28423F3-540F-4242-A23B-79C0BC6BB04CQ38835365-D2B82E8A-68EC-48FA-87B3-A57947F9C109Q38881849-2836C33E-9E4B-4686-A47D-EF62F1633365Q38884056-CA3C70E0-0999-410F-BAEB-5F73561CCF3CQ38937720-DC971874-6F36-4A3D-BB5B-D34BC6F59E9BQ38946940-CF3BB3CE-641E-4CEF-86A7-8BDF1AD97BB4Q38973304-6A5D5D24-0131-4C50-AA0E-3D75CEBD38D8Q38987093-445DE409-C205-45DD-9648-DBC355281ED5
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The global burden of IBD: from 2015 to 2025.
@en
type
label
The global burden of IBD: from 2015 to 2025.
@en
prefLabel
The global burden of IBD: from 2015 to 2025.
@en
P2860
P1476
The global burden of IBD: from 2015 to 2025.
@en
P2860
P2888
P304
P356
10.1038/NRGASTRO.2015.150
P407
P577
2015-09-01T00:00:00Z
P6179
1003936311